Brief: Oncopeptides Submits Type II Variation Application To EMA

Oncopeptides AB

12/06/2026 12:00

June 12 (Reuters) - Oncopeptides AB ONCO.ST:
SUBMITS TYPE II VARIATION APPLICATION TO EMA
EMA REGULATORY PROCEDURE FOR ONCOPEPTIDES APPLICATION TO START JUNE 20, 2026
EXPECTS CHMP OPINION ON APPLICATION BETWEEN SEPTEMBER-NOVEMBER 2026
EUROPEAN COMMISSION FINAL DECISION EXPECTED 30-60 DAYS AFTER POSITIVE CHMP OPINION
SEES SIGNIFICANT ADDITIONAL COMMERCIAL POTENTIAL FROM THIRD-LINE APPROVAL
Source text: ID:nMFN7p9mlY
Further company coverage: ONCO.ST

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))